HENDERSON, Nev., Sept. 29, 2025 /PRNewswire/ -- VolitionRx Limited (VNRX) (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces that it has signed an agreement with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results